MANAGEMENT OF INFERTILITY

摘要

A method is disclosed detecting whether a female patient is likely to benefit from combined GH/gonadotropin or GHRH/gonadotropin therapy. The method involves administering to the patient a predetermined dose of clonidine or a pharmaceutically acceptable derivative thereof, monitoring the blood level of GH following administration of said clonidine or derivative, and detecting whether the peak blood level of GH is above a predetermined minimum value.